These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25042806)

  • 1. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.
    Goodwin JM; Svensson RU; Lou HJ; Winslow MM; Turk BE; Shaw RJ
    Mol Cell; 2014 Aug; 55(3):436-50. PubMed ID: 25042806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
    Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
    Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.
    Fogarty S; Hardie DG
    J Biol Chem; 2009 Jan; 284(1):77-84. PubMed ID: 18854318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
    Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
    Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT.
    Kaufman JM; Amann JM; Park K; Arasada RR; Li H; Shyr Y; Carbone DP
    J Thorac Oncol; 2014 Jun; 9(6):794-804. PubMed ID: 24828662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
    Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
    Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
    Molina E; Hong L; Chefetz I
    J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
    Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
    Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
    Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
    Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
    Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
    Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity.
    Houde VP; Ritorto MS; Gourlay R; Varghese J; Davies P; Shpiro N; Sakamoto K; Alessi DR
    Biochem J; 2014 Feb; 458(1):41-56. PubMed ID: 24295069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous activation of LKB1/AMPK signaling induces G₁ arrest in cells with endogenous LKB1 expression.
    Liang X; Wang P; Gao Q; Tao X
    Mol Med Rep; 2014 Mar; 9(3):1019-24. PubMed ID: 24469340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.
    Lizcano JM; Göransson O; Toth R; Deak M; Morrice NA; Boudeau J; Hawley SA; Udd L; Mäkelä TP; Hardie DG; Alessi DR
    EMBO J; 2004 Feb; 23(4):833-43. PubMed ID: 14976552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
    J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
    Chen Y; Liu Y; Zhou Y; You H
    Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.